Evidence map›Paper›PMID 31628396›Full record

ArticleScientific reports2019

Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice.

Arezoo Daryadel, Luciano Natale, Petra Seebeck, Carla Bettoni, Udo Schnitzbauer, Max Gassmann, Carsten A Wagner

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Erythropoietin treatment and the risk of hip fractures in hemodialysis patients.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  8. Article
  9. Upstream Regulators of Fibroblast Growth Factor 23.Frontiers in endocrinology · 2021
    Review
  10. Osteocytic FGF23 and Its Kidney Function.Frontiers in endocrinology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Arezoo DaryadelInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Luciano NataleInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Petra SeebeckZurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland.
Carla BettoniInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Udo SchnitzbauerInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Max GassmannZurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland.
Carsten A WagnerInstitute of Physiology, University of Zurich, Zurich, Switzerland. Wagnerca@access.uzh.ch.ORCID http://orcid.org/0000-0002-9874-8898
University of Zurich · CHUniversidad Peruana Cayetano Heredia · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblast Growth Factor 23 (FGF23) is a phosphaturic factor causing increased renal phosphate excretion as well as suppression of 1,25 (OH)

Indexed as

Amino AcidsAnimalsBone DensityCalcification, PhysiologicCalcitriolCalciumErythropoietinFemaleFibroblast Growth Factor-23Fibroblast Growth FactorsHomeostasisKidneyMiceMice, Inbred C57BLMice, TransgenicMineralsAmino AcidsCalcitriolCalciumdeoxypyridinolineEPO protein, humanErythropoietinFGF23 protein, humanFgf23 protein, mouseFibroblast Growth Factor-23Fibroblast Growth FactorsMineralsOsteocalcinPhosphates

Identifiers

PMID31628396
PMCPMC6802194
OpenAlexW2981306868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.